The MODS Assay for Detection of TB and TB Drug Resistance: A Multi-center Study

Similar documents
Clinical Evaluation of the Microscopic-Observation Drug-Susceptibility Assay for Detection of Tuberculosis

Evaluation of the Microscopic-Observation. Drug-Susceptibility Assay Drugs Concentration for Detection Of Multidrug-Resistant Tuberculosis

Overview of Mycobacterial Culture, Identification, and Drug Susceptibility Testing

TB 101 Disease, Clinical Assessment and Lab Testing

Ken Jost, BA, has the following disclosures to make:

TB Laboratory for Nurses

TB Intensive San Antonio, Texas November 11 14, 2014

Laboratory Diagnostic Techniques. Hugo Donaldson Consultant Microbiologist Imperial College Healthcare NHS Trust

Original Article Evaluation of Xpert MTB/RIF in detection of pulmonary and extrapulmonary tuberculosis cases in China

Evaluation of Genxpert Real Time PCR POC in the Diagnosis of Multidrug Resistant TB Among Patients Attending NTBLTC Saye-Zaria Nigeria

How best to structure a laboratory network with new technologies

Abstract. Introduction. Editor: M. Drancourt

Diagnosis of TB: Laboratory Ken Jost Tuesday April 1, 2014

Receipt within 1 day of specimen collection. Report AFB b smear result within 1 day from receipt of specimen

Comparative performance of emerging rapid diagnostics in HIV-infected individuals

Introduction. Diagnosis of extrapulmonaryand paediatric tuberculosis. Extrapulmonary tuberculosis EPTB SASCM WORKSHOP 2014/05/24

TB/HIV 2 sides of the same coin. Dr. Shamma Shetye, MD Microbiology Metropolis Healthcare, Mumbai

Stacy White, PhD May 12, TB for Community Providers. Phoenix, Arizona

Tuberculosis Reference Laboratory, NIDCH, Mahakhali, Dhaka.

Nucleic Acid Amplification Testing for the Diagnosis of TB

Rapid PCR TB Testing Results in 68.5% Reduction in Unnecessary Isolation Days in Smear Positive Patients.

Clinical Diagnostics Research Consortium (CDRC)

Frances Morgan, PhD October 21, Comprehensive Care of Patients with Tuberculosis and Their Contacts October 19 22, 2015 Wichita, KS

Principles of laboratory diagnosis of M. tuberculosis. Anne-Marie Demers, MD, FRCPC 11 September 2017

CDPH - CTCA Joint Guidelines Guideline for Micobacteriology Services In California

Towards Harmonization of Mycobacteriology in TB Trials. Study 31/ACTG 5349 Key Elements of Mycobacteriology Laboratory Procedures

Diagnosis of drug resistant TB

Drug susceptibility testing for tuberculosis KRISTEN DICKS, MD, MPH DUKE UNIVERSITY MEDICAL CENTER

Diagnosis of TB: Laboratory Ken Jost Tuesday April 9, 2013

Characteristics of Mycobacterium

The ABC s of AFB s Laboratory Testing for Tuberculosis. Gary Budnick Connecticut Department of Public Health Mycobacteriology Laboratory

A retrospective evaluation study of diagnostic accuracy of Xpert MTB/RIF assay, used for detection of Mycobacterium tuberculosis in Greece

Objectives. TB Laboratory Methods

The Lancet Infectious Diseases

Biology and Medicine

Title: Role of Interferon-gamma Release Assays in the Diagnosis of Pulmonary Tuberculosis in Patients with Advanced HIV infection

Standard Diagnostic Procedure for Tuberculosis: A Review

POSITIONING OF TB DX : TIERED SYSTEM, INTEGRATED APPROACH

Public Health Mycobacteriology (TB) Laboratory Testing Services

TB NAAT testing at the Los Angeles County Public Health Laboratory

New Tuberculosis Guidelines. Jason Stout, MD, MHS

Microscopic Morphology in Smears Prepared from MGIT Broth Medium for Rapid Presumptive Identification of Mycobacterium tuberculosis

Elizabeth A. Talbot MD Assoc Professor, ID and Int l Health Deputy State Epidemiologist, NH GEISELMED.DARTMOUTH.EDU GEISELMED.DARTMOUTH.

Diagnosis of tuberculosis

MULTIDRUG- RESISTANT TUBERCULOSIS. Dean Tsukayama Hennepin County Medical Center Hennepin County Public Health Clinic

EVALUATION OF THE BACTEC MGIT 960 TB SYSTEM FOR RECOVERY

Rapid detection of multidrug-resistant Mycobacterium tuberculosis using the mycobacteria growth indicator tube (MGIT) system

Latent Tuberculosis Infections Controversies in Diagnosis and Management Update 2016

New Standards for an Old Disease:

Rapid Diagnosis and Detection of Drug Resistance in Tuberculosis

MIC = Many Inherent Challenges Sensititre MIC for Antimicrobial Susceptibility Testing of Mycobacterium tuberculosis complex

Original Article INTRODUCTION. Abstract

Supplementary appendix

Mycobacteria Diagnostic Testing in Manitoba. Dr. Michelle Alfa Medical Director, DSM Clin Micro Discipline

A comparative evaluation of mycobacteria growth indicator tube and Lowenstein-Jensen medium for the isolation of mycobacteria from clinical specimens

TB Nurse Case Management San Antonio, Texas April 9-11, 2013

Clinical and Public Health Impact of Nucleic Acid Amplification Tests (NAATs) for Tuberculosis

SMEAR MICROSCOPY AS SURROGATE FOR CULTURE DURING FOLLOW UP OF PULMONARY MDR-TB PATIENTS ON DOTS PLUS TREATMENT

TB Prevention in PLHIV: Options Other Than Isoniazid. Johns Hopkins Center for Tuberculosis. Research. Richard E. Chaisson, MD

Mycobacterial cell wall. Cell Cycle Lengths. Outline of Laboratory Methods. Laboratory Methods

TB Nurse Case Management. March 7-9, Diagnosis of TB: Ken Jost Wednesday March 7, 2012

Multi-Site Performance Summary of. AEROSPRAY TB SLIDE STAINER/CYTOCENTRIFUGE (Model 7722)

AFB Identification Texas Approach

Research Methods for TB Diagnostics. Kathy DeRiemer, PhD, MPH University of California, Davis Shanghai, China: May 8, 2012

Diagnosis and Treatment of Tuberculosis, 2011

Pelin Yuksel*, Suat Saribas and Yasar Bagdatli

11/3/2009 SECOND EDITION Madhukar Pai McGill University. ISTC Training Modules Introduction

MDR, XDR and Untreatable Tuberculosis and Laboratory Perspectives. Martie van der Walt TUBERCULOSIS EPIDEMIOLOGY & INTERVENTION RESEARCH UNIT

Rapid Detection of Rifampin Resistance 江振源主任

International Standards for Tuberculosis Care Barbara J. Seaworth, MD August 22, 2007

Title: Meta-analysis of Individual patient Data (IPD) of Patients with INH (mono or poly-drug) Resistant Tuberculosis.

INDEX CASE INFORMATION

Xpert MTB/RIF assay validation experience --- impact and plan in China

Int.J.Curr.Microbiol.App.Sci (2018) 7(5):

GLI Partners Meeting 18 th April Ivor Langley (LSTM) & Afrânio Kritski (Rede-TB)

TB BASICS: PRIORITIES AND CLASSIFICATIONS

Rapid Diagnostic Techniques for Identifying Tuberculosis Ken Jost November 13, 2008

MYCOBACTERIA. Pulmonary T.B. (infect bird)

Assessing the programmatic management of drug-resistant TB

TB is Local. Barry Chin, Boston Globe, 10/15/2008. * BUT only in appropriate setting

Revised National Tuberculosis Control Programme (RNTCP) Dr.Kishore Yadav J Assistant Professor

Community-Based Surveillance for Drug Resistance of Mycobacterium tuberculosis in Selected Areas in the Philippines

Konjit Getachew, 1 Tamrat Abebe, 2 Abebaw Kebede, 3 Adane Mihret, 2,4 and Getachew Melkamu Introduction

TB prevention studies in PLHIV: recent updates and what can they tell us for the future?

ORIGINAL ARTICLE AFRICAN JOURNAL OF CLINICAL AND EXPERIMENTAL MICROBIOLOGY JANUARY2012 ISBN X VOL 13(1)

EQUIVALENCE OF ACID ALONE OR ACID-ALCOHOL AS DECOLOURIZING AGENT IN ZIEHL - NEELSEN METHOD

Recognizing MDR-TB in Children. Ma. Cecilia G. Ama, MD 23 rd PIDSP Annual Convention February 2016

Diagnosing Xpert MTB/RIF negative TB suspects: Impact and cost of an alternative algorithm

Jessica Minion 1,2, Erika Leung 1,2, Dick Menzies 1,2, Madhukar Pai 1,2. Contact:

Treatment of Active Tuberculosis

Management of MDR TB. Dr Priscilla Rupali MD; DTM&H Professor and Head Department of Infectious Diseases Christian Medical College Vellore

Heather Alexander, PhD

Molecular tests for rapid detection of rifampicin and isoniazid resistance in Mycobacterium tuberculosis.

Diagnosis and Medical Management of Latent TB Infection

Rapid Diagnosis of Tuberculosis and Multidrug Resistance Using a MGIT 960 System

Rapid diagnosis of pleural tuberculosis by Xpert MTB/RIF assay using pleural biopsy and pleural fluid specimens

Laboratory diagnosis of spinal tuberculosis: Past and Present. SA Patwardhan, S Joshi Abstract : Spinal tuberculosis often has an indolent course and

Role of Xpert MTB/RIF Assay in the Diagnosis of Pulmonary Tuberculosis and Rifampicin Resistance

ORIGINAL ARTICLE. Department of Microbiology, Military Medical Academy, Belgrade, Yugoslavia. Clin Microbiol Infect 2002; 8:

New frontiers: Innovation and Access

Transcription:

The MODS Assay for Detection of TB and TB Drug Resistance: A Multi-center Study microscopic observation drug susceptibility Susan E. Dorman, MD Johns Hopkins University Afranio L. Kritski, MD, PhD Federal University of Rio de Janeiro June 1, 2006

Rio de Janeiro ICIDR Program Community randomized trial of 2 TB prevention strategies Randomized trial of two TB chemoprevention strategies Novel diagnostic techniques for TB and TB drug resistance

Rio de Janeiro ICIDR Program Community randomized trial of 2 TB prevention strategies Randomized trial of two TB chemoprevention strategies Novel diagnostic techniques for MODS TB and TB drug resistance Study

What is MODS? microscopic observation drug susceptibility Pioneered by Robert Gilman in Peru Liquid culture method for detection of M. tuberculosis Microscopic detection of bacterial cording that is characteristic for M. tuberculosis Can be adapted for drug susceptibility testing Relatively simple, relatively inexpensive, no radioactivity

What is MODS? MODS assay culture plate cording of M. tuberculosis

Study Objectives To evaluate sensitivity and specificity of MODS for detection of M. tuberculosis in respiratory specimens from pulmonary TB suspects in disease endemic settings To evaluate the time to growth for M. tuberculosis in MODS versus Lowenstein-Jensen, and versus MGIT 960 To evaluate the sensitivity and specificity of MODS for direct detection of isoniazid and rifampin drug resistance At study sites, to increase capacity to evaluate new TB diagnostic tests using Good Laboratory Practices, and to facilitate South-South collaboration

Study Design Prospective, multicenter Federal University of Rio de Janeiro, Brazil Instituto Nacional del Torax, Honduras Respiratory specimens obtained from pulmonary TB suspects (~ 70% outpatients) Comparators Clinical diagnosis of TB (includes LJ culture results) Companion Lowenstein-Jensen culture Sample size 1655 respiratory specimens

Study Scheme respiratory specimen smear microscopy Lowenstein- Jensen culture MODS culture Direct MODS DST isoniazid rifampin MGIT culture Indirect LJ DST isoniazid rifampin

Characteristics of 854 Study Subjects (adult pulmonary TB suspects) Characteristic # % Brazil Honduras Male Female Type of Subject New TB suspect Suspected TB relapse Suspected TB treatment failure Suspected TB treatment defaulter HIV positive HIV negative HIV not tested 559 295 491 363 521 178 113 42 102 297 455 65.5 34.5 57.5 42.5 61.0 20.8 13.2 4.9 11.9 34.8 53.3

Characteristics of 1639 Study Specimens Characteristic # % Brazil Honduras 977 662 59.6 40.4 Expectorated sputum Induced sputum Bronchoalveolar lavage/bronch wash 1353 237 49 82.5 14.5 3.0

Overall Results (by specimen) # % AFB smear positive 594 36.2 LJ culture positive for M. tuberculosis MODS culture positive for M. tuberculosis 681 41.5 728 44.4 LJ culture positive for NTM 17 2.0

Proportions of contaminated cultures for Lowenstein-Jensen and MODS % contaminated 10 9 8 7 6 5 4 3 2 1 0 p < 0.001 5% LJ MODS

Performance characteristics of MODS for detection of TB TB Diagnosis Companion LJ Sensitivity (%) 97.5* 96.5 Specificity (%) 95.1 92.6 PPV (%) 93.6 90.2 NPV (%) 98.1 97.4 Agreement (%) N/A 94.2 *LJ sensitivity 98.9% difference 1.4%, 95% CI -0.5 to 2.7; p=0.27

Time to growth for culture positive specimens, by culture method Days to growth of M. tuberculosis 55 50 45 40 35 30 25 20 15 10 5 For LJ and MODS: N=657 specimens p < 0.0001 For MGIT: N=64 specimens p = 0.16 for MODS vs MGIT LJ MODS MGIT

Time to growth, by culture method and smear microscopy status 100 90 % positive for growth 80 70 60 50 40 30 20 10 Smear negative, N=135 Smear positive, N=522 LJ, smear negative MODS, smear negative LJ, smear positive MODS, smear positive 0 0 5 10 15 20 25 30 35 40 45 50 55 Days to M. tuberculosis grow th

Overall Drug Susceptibility Test Results Lowenstein-Jensen Result # % Susceptible to INH and RIF 69 36.7 INH resistant 35 18.6 RIF susceptible INH susceptible 13 6.9 RIF resistant Resistant to INH and RIF 71 37.8 N = 188 study subjects having risk factor(s) for drug resistant TB

Performance characteristics of MODS for detection of drug resistance Isoniazid Rifampin Sensitivity (%) 97.2 96.4 Specificity (%) 89.0 86.5 PPV (%) 92.0 85.3 NPV (%) 96.1 96.8 Agreement (%) 93.6 91.0 Comparator: Lowenstein-Jensen N=188 subjects with risk factor(s), and positive LJ and MODS cx

Summary For diagnosis of pulmonary TB, MODS has good sensitivity, which is similar to that of LJ MODS has an acceptable contamination rate Time to detection of MODS growth is about one-third that of LJ, and similar to MGIT MODS identifies as TB some non-tuberculous mycobacteria MODS is sensitive for detection of isoniazid or rifampin resistance MODS indicates as resistant some cultures that are susceptible to INH or rifampin MODS performed similarly at both study sites

Conclusions Rapidity of growth and low contamination rates make MODS an attractive platform Inability to accurately differentiate M. tuberculosis from some non-tuberculous mycobacteria may be problematic in some settings Good sensitivity, high NPV, and short turnaround time of MODS for direct detection of INH and/or RIF resistance might make MODS suitable as a screening test in order to prioritize isolates for subsequent confirmatory indirect testing using conventional methods

Acknowledgements Federal Univ of Rio de Janeiro Fernanda Mello Anna Grazia Marsico Leo Pessoa Monica Andrade Leila Fonseca Afranio Kritski Johns Hopkins University Richard Chaisson National Thorax Institute, Honduras Ada Pavon Carlos Alvarado-Galvez Senia Rosales Melly Perez University of Alabama Mayra Arias Michael Kimerling NIH / DMID USAID

Laboratory Methods Respiratory specimens were obtained from TB suspects undergoing evaluation for TB Specimens were processed using a NALC-NaOH method of decontamination/mucolysis LJ culture and indirect drug susceptibility testing for INH and RIF were performed according to published standards 0.2 ml each processed respiratory specimen was inoculated into 1 ml of MODS/PANTA 7H9-based liquid media, and into 1 ml of MODS/PANTA medium containing para-nitrobenzoic acid For MODS direct drug susceptibility testing, INH concentration was 0.1 ug/ml, and RIF concentration was 2.0 ug/ml. MODS wells were observed microscopically under 40X magnification at a frequency of twice weekly For LJ cultures, standard biochemical tests were used to determine mycobacterial species For MODS cultures, cording morphology and absence of growth in PNB were considered diagnostic of M. tuberculosis